Application of the brace framework for benefit-risk assessment, communication, and evaluation of Pexidartinib

被引：0
|
作者：
Wang, Eric [1 ]
Dharmani, Charles [1 ]
Salas, Maribel [1 ]
机构：
[1] Daiichi Sankyo Inc, Tokyo, Japan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2022年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
333
引用
收藏
页码：145 / 146
页数：2
相关论文
共 50 条
  • [31] Incorporation of a Benefit-Risk Assessment Framework Into the Clinical Overview of Marketing Authorization Applications
    Anne Wolka
    Margaret Warner
    Kristin Bullok
    JuAn Wang
    Christine Radawski
    Rebecca Noel
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 130 - 134
  • [32] Is there a need for a universal benefit-risk assessment framework for medicines? Regulatory and industry perspectives
    Leong, James
    McAuslane, Neil
    Walker, Stuart
    Salek, Sam
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (09) : 1004 - 1012
  • [33] Benefit-Risk Assessment of Orlistat in the Treatment of Obesity
    Priya Sumithran
    Joseph Proietto
    Drug Safety, 2014, 37 : 597 - 608
  • [34] A Benefit-Risk Assessment of Caffeine as an Analgesic Adjuvant
    Wei-Ya Zhang
    Drug Safety, 2001, 24 : 1127 - 1142
  • [35] Benefit-Risk Assessment of Raloxifene in Postmenopausal Osteoporosis
    Ann Cranney
    Jonathan D. Adachi
    Drug Safety, 2005, 28 : 721 - 730
  • [36] On a Stepwise Quantitative Approach for Benefit-Risk Assessment
    He, Weili
    Sun, Yaxuan
    Li, Qing
    Wan, Sabrina
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2017, 51 (05) : 625 - 634
  • [37] Benefit-Risk Assessment of Orlistat in the Treatment of Obesity
    Sumithran, Priya
    Proietto, Joseph
    DRUG SAFETY, 2014, 37 (08) : 597 - 608
  • [38] A Benefit-Risk Assessment of Sibutramine in the Management of Obesity
    Enzo Nisoli
    Michele O. Carruba
    Drug Safety, 2003, 26 : 1027 - 1048
  • [39] Benefit-risk assessment of vitamin D supplementation
    Bischoff-Ferrari, H. A.
    Shao, A.
    Dawson-Hughes, B.
    Hathcock, J.
    Giovannucci, E.
    Willett, W. C.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 (07) : 1121 - 1132
  • [40] A Benefit-Risk Assessment of Basiliximab in Renal Transplantation
    Ugo Boggi
    Romano Danesi
    Fabio Vistoli
    Marco Del Chiaro
    Stefano Signori
    Piero Marchetti
    Mario Del Tacca
    Franco Mosca
    Drug Safety, 2004, 27 : 91 - 106
12345